Outcomes in transplant patients undergoing brachytherapy for prostate cancer

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 35, Issue 1, 2012, Pages 40-44

  Coombs, Catherine Callaghan ^a   Hertzfeld, Kara ^a   Barrett, William ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

brachytherapy; immunosuppression; outcomes research; prostate cancer; transplant

Indexed keywords

ANTINEOPLASTIC AGENT; AZATHIOPRINE; CYCLOSPORIN; FLUDROCORTISONE; HYDROXYCHLOROQUINE; HYDROXYUREA; IODINE 125; LEFLUNOMIDE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; PREDNISONE; PROSTATE SPECIFIC ANTIGEN; TACROLIMUS;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CARDIAC GRAFT REJECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROHN DISEASE; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GRAFT RECIPIENT; HEART GRAFT; HUMAN; HYPOPITUITARISM; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; OUTCOME ASSESSMENT; POLYCYTHEMIA VERA; PROSTATE CANCER; PSORIASIS; RETROSPECTIVE STUDY; RHEUMATIC POLYMYALGIA; RHEUMATOID ARTHRITIS; TREATMENT FAILURE;

AGED; BRACHYTHERAPY; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; ORGAN TRANSPLANTATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84856289615     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e31820059b6     Document Type: Article

References (40)

1. di Capua Sacoto C, Luján Marco S, Bahilo Mateu P, et al. De novo urological neoplasms in kidney transplant patients: experience in 1751 patients. Actas Urol Esp. 2010;34:88-94.
2. Chen PL, Chang HH, Chen IM, et al. Malignancy after heart transplantation. J Chin Med Assoc. 2009;72:588-593.
3. Muruve NA, Shoskes DA. Genitourinary malignancies in solid organ transplant recipients. Transplantation. 2005;80:709-716. (Pubitemid 41443750)
4. Barrett WL, First MR, Aron BS, et al. Clinical course of malignancies in renal transplant recipients. Cancer. 1993;72:2186-2189. (Pubitemid 23280145)
5. Miao Y, Everly JJ, Gross TG, et al. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population. Transplantation. 2009;87:1347-1359.
6. Breyer BN, Whitson JM, Freise CE, et al. Prostate cancer screening and treatment in the transplant population: current status and recommendations. J Urol. 2009;181:2018-2025.
7. Herrero JI. De novo malignancies following liver transplantation: impact and recommendations. Liver Transpl. 2009;15(suppl 2): S90-S94.
8. Einollahi B, Simforoosh N, Lessan-Pezeshki M, et al. Genitourinary tumor following kidney transplantation: a multicenter study. Transplant Proc. 2009;41:2848-2849.
9. Kellerman L, Neugut A, Burke B, et al. Comparison of the incidence of de novo solid malignancies after heart transplantation to that in the general population. Am J Cardiol. 2009;103:562-566.
10. Webster AC, Craig JC, Simpson JM, et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant. 2007;7:2140-2151. (Pubitemid 47247055)
11. Diller R, Gruber A, Wolters H, et al. Therapy and prognosis of tumors of the genitourinary tract after kidney transplantation. Transplant Proc. 2005;37:2089-2092. (Pubitemid 40956381)
12. Vajdic CM, McDonald SP, McCredie MR, et al. Cancer incidence before and after kidney transplantation. JAMA. 2006;296:2823-2831. (Pubitemid 44969182)
13. Kleinclauss F, Gigante M, Neuzillet Y, et al. Prostate cancer in renal transplant recipients. Renal Transplantation Committee of the French Urological Association (AFU). Nephrol Dial Transplant. 2008;23:2374-2380.
14. Kessler M, Jay N, Molle R, et al. Excess risk of cancer in renal transplant patients. Transpl Int. 2006;19:908-914. (Pubitemid 44511115)
15. Wicht A, Hamza A, Loertzer H, et al. Diagnostics and treatment of prostate cancer after kidney transplantation. Urologe A. 2006;45: 32-37. (Pubitemid 43155420)
16. Ajithkumar TV, Parkinson CA, Butler A, et al. Management of solid tumours in organ-transplant recipients. Lancet Oncol. 2007;8:921-932. (Pubitemid 47488067)
17. Mohammadi S, Silvaggio G, Bonnet N, et al. Prostate cancer after heart transplantation: unicenter case-control study. J Heart Lung Transplant. 2005;24:995-997. (Pubitemid 41127179)
18. Kasiske BL, Snyder JJ, Gilbertson DT, et al. Cancer after kidney transplantation in the United States. Am J Transplant. 2004;4: 905-913. (Pubitemid 38745589)
19. Cormier L, Lechevallier E, Barrou B, et al. Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation. 2003;75:237-239. (Pubitemid 36139680)
20. Walsh PC, DeWeese TL, Eisenberger MA. Clinical practice. Localized prostate cancer. N Engl J Med. 2007;357:2696-2705.
21. Ash DV. Management of localized carcinoma of the prostate: Brachytherapy revisited. Clin Oncol. 1997;9:219-221. (Pubitemid 27450095)
22. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med. 2008;148:435-448. (Pubitemid 351665443)
23. Eckman MH, Ying J, Hertzfeld K, et al. Longitudinal analysis of genitourinary and bowel symptoms in prostate cancer patients following brachytherapy. Am J Clin Oncol. 2010;33:1-10.
24. Lin GA, Aaronson DS, Knight SJ, et al. Patient decision aids for prostate cancer treatment: a systematic review of the literature. CA Cancer J Clin. 2009;59:379-390.
25. Whang M, Geffner S, Khachikian Z, et al. Renal transplantation and prostate cancer: guidelines for screening and treatment. Transplant Proc. 2002;34:3196-3199. (Pubitemid 35469156)
26. Abramowitz MC, Li T, Buyyounouski MK, et al. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008;112:55-60.
27. Elkentaoui H, Robert G, Pasticier G, et al. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux. Urology. 2010;75: 126-132.
28. Prestwich RJ, Errington F, Hatfield P, et al. The immune system is it relevant to cancer development, progression and treatment? Clin Oncol (R Coll Radiol). 2008;20:101-112. (Pubitemid 351194288)
29. Robert G, Elkentaoui H, Pasticier G, et al. Laparoscopic radical prostatectomy in renal transplant recipients. Urology. 2009;74: 683-687.
30. Antonopoulos IM, Nahas WC, Piovesan AC, et al. Radical retropubic prostatectomy for localized prostate cancer in renal transplant patients. Urology. 2008;72:1362-1365.
31. Kleinclauss FM, Neuzillet Y, Tillou X, et al. Morbidity of retropubic radical prostatectomy for prostate cancer in renal transplant recipients: multicenter study from Renal Transplantation Committee of French Urological Association. Urology. 2008;72:1366-1370.
32. Thomas AA, Nguyen MM, Gill IS. Laparoscopic transperitoneal radical prostatectomy in renal transplant recipients: a review of three cases. Urology. 2008;71:205-208. (Pubitemid 351282372)
33. Campagnari JC, Ribeiro LA, Mangini M, et al. Localized prostatic cancer in patients submitted to renal transplant. Int Braz J Urol. 2002;28:330-334. (Pubitemid 36322439)
34. Mouzin M, Bachaud JM, Kamar N, et al. Three-dimensional conformal radiotherapy for localized prostate cancer in kidney transplant recipients. Transplantation. 2004;78:1496-1500. (Pubitemid 39552936)
35. Hertzfeld KE, Shirazi R, Barrett W. Efficacy of brachytherapy for prostate cancer in organ transplant patients. Abstract 133, 2005 Prostate Cancer Symposium.
36. Blackwelder WC. "Proving the null hypothesis" in clinical trials. Control Clin Trials. 1982;3:345-353. (Pubitemid 13113168)
37. Blackwelder WC, Chang MA. Sample size graphs for "Proving the Null Hypothesis." Control Clin Trials. 1984;5:97-105. (Pubitemid 14025834)
38. Patten SB. Sample Size for Equivalence Studies [University of Calgary, Hotchkiss Brain Institute]. Available at http://people. ucalgary.ca/Bpatten/ blackwelder.html
39. Woodle ES, Gupta M, Buell JF, et al. Prostate cancer prior to solid organ transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37: 958-959. (Pubitemid 40590758)
40. Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant. 2003;3:619-625. (Pubitemid 36612846)